🔴 Sionna Therapeutics is trading 8.23% down in pre-market; no company-specific announcement identified

Sionna Therapeutics is trading at $3.01, down 8.23% in pre-market; no new company-specific announcement was found to explain the November 6 move.

• Its latest release announced investor conference appearances.
• The decline follows a 12.06% drop on November 5 amid broad biotech and healthcare weakness; the XBI biotech ETF fell 6.73% that session.
• November 5 volume was 876,517 shares, versus a 30-day average of 953,183.